Delivering small interfering RNA (siRNA) to the central nervous system (CNS) holds great promise for silencing disease-related genes in neurodegenerative disorders, brain tumors, and neuroinflammatory conditions. However, effective delivery of siRNA to brain cells is challenging due to its instability, negative charge, and inability to cross the blood-brain barrier (BBB). Polymeric micelles and dendrimers have…
Microglia are the primary immune cells of the central nervous system and play key roles in homeostasis, synaptic pruning, and neuroinflammation. Despite their importance in neurobiology and brain pathology, transfecting microglia in vivo remains a formidable challenge. These cells possess an active endolysosomal system, rapidly degrade foreign nucleic acids, and are highly responsive to pattern…
CRISPR/Cas9 genome editing has revolutionized neuroscience by enabling targeted manipulation of genes involved in brain development, function, and disease. Delivering CRISPR components into brain tissue, however, presents technical and biological challenges that are not present in standard in vitro systems. Achieving efficient on-target editing in neurons and glial cells requires precise delivery of Cas9 and…
Electroporation has emerged as a valuable method for non-viral gene delivery to the rodent brain, particularly in applications where high spatial precision and transient expression are required. By applying brief, high-voltage electrical pulses, this technique temporarily permeabilizes cell membranes, allowing plasmid DNA, mRNA, or other nucleic acids to enter the cytoplasm. When applied to the…
In brain transfection research, accurate quantification of gene delivery and expression is essential for validating experimental success and understanding spatial distribution within neural tissue. Traditional histological methods, while informative, are often invasive, endpoint-based, and time-consuming. Advances in in vivo imaging—particularly bioluminescence and multiplexed fluorescent reporter systems—have transformed how researchers monitor transfection outcomes in the brain….
Delivering genetic material across the blood–brain barrier (BBB) presents one of the most persistent challenges in central nervous system research. The BBB is highly selective, preventing most macromolecules, including DNA and RNA-based therapeutics, from entering the brain parenchyma. While viral vectors like AAVs have demonstrated some success, non-viral nanocarriers have gained increasing interest due to…
Achieving efficient gene expression in post-mitotic neurons remains one of the central challenges in neurobiology and gene therapy research. While promoter selection is often the first step toward targeting specific neuronal populations, it is far from sufficient on its own. Neurons present a unique set of obstacles due to their terminal differentiation, low rates of…
Neurotrophic factor gene therapy is a promising approach aimed at promoting neuroregeneration and enhancing the survival and function of neurons in various neurological disorders. Neurotrophic factors are a group of naturally occurring proteins that support the growth, survival, and maintenance of neurons. By delivering genes encoding neurotrophic factors into the nervous system, gene therapy can…
CRISPR-Cas9 is a revolutionary gene editing technology that has emerged as a powerful tool for manipulating the genome with unprecedented precision. It has significant applications in brain transfection, allowing researchers to modify specific genes in neural cells and study their functions or develop potential therapeutic interventions. Here are some key applications of CRISPR-Cas9 in brain…
Stem cell-based gene therapy holds great promise for the treatment of neurological disorders. This approach involves combining the regenerative potential of stem cells with the therapeutic benefits of gene therapy to target and repair specific cell populations affected by neurological conditions. Here’s an overview of stem cell-based gene therapies for neurological disorders: Stem cell-based gene…
